Faiz Anwer

70PUBLICATIONS
212CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Ngā kōhanga reo (Māori curriculum and pedagogy)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Oct 23, 2026
Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium.

|Jun 03, 2026
Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention.

|Apr 23, 2026
Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Jan 12, 2026
Multiple Myeloma Management in a Large Low- and Middle-Income Country: Lessons From India in Balancing Cost and Clinical Efficacy in Resource-Limited Settings.

Prabhat Gautam Roy, Ajay Gogia, Zain Anwar

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

Pageof 12

Frequent Collaborators

23 joint publications

Jack Khouri

22 joint publications

Shahzad Raza

15 joint publications

James A Davis

13 joint publications

Danai Dima